Page last updated: 2024-10-30

mecamylamine and Dystonic Disorders

mecamylamine has been researched along with Dystonic Disorders in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kutschenko, A1
Staege, S1
Grütz, K1
Glaß, H1
Kalmbach, N1
Gschwendtberger, T1
Henkel, LM1
Heine, J1
Grünewald, A1
Hermann, A1
Seibler, P1
Wegner, F1

Other Studies

1 other study available for mecamylamine and Dystonic Disorders

ArticleYear
Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons.
    International journal of molecular sciences, 2021, Mar-30, Volume: 22, Issue:7

    Topics: Acetylcholine; Action Potentials; Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium

2021